A lawsuit challenges Louisiana's law classifying abortion drugs as controlled substances, citing risks.

A lawsuit has been filed against Louisiana's new law that classifies abortion drugs mifepristone and misoprostol as "controlled dangerous substances." Critics, including healthcare providers and patients, argue the law creates life-threatening delays in emergencies, particularly for postpartum hemorrhages, due to added restrictions. Proponents claim the law is necessary to prevent coerced abortions. The plaintiffs contend the law is unconstitutional and discriminatory.

October 31, 2024
39 Articles